BRCA2 and neoplasm: And, smMIPS sequencing has also recently been applied clinically to test for mutations in the tumor suppressor genes BRCA1 and BRCA2 (Neveling et al., 2017) and has demonstrated superior accuracy and turnaround time relative to previous laboratory‐developed testing.